EDGAR Filing Documents for 0001493152-23-043499

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001493152-23-043499

Filing Date

2023-12-04

Accepted

2023-12-04 07:00:18

Documents

Period of Report

2023-12-04

Document Format Files

Seq	Description	Document	Type	Size
1		form6-k.htm	6-K	27852
2		ex99-1.htm	EX-99.1	17283
3		ex99-1_001.jpg	GRAPHIC	5649
	Complete submission text file	0001493152-23-043499.txt		53953

Mailing Address 55 PARK LANE LONDON X0 W1K 1NA

Business Address 55 PARK LANE LONDON X0 W1K 1NA 44 (0) 207 495 2379

OKYO Pharma Ltd (Filer) CIK: 0001849296 (see all company filings)

IRS No.: 000000000
Type: 6-K | Act: 34 | File No.: 001-41386 | Film No.: 231461285
SIC: 2836 Biological Products, (No Diagnostic Substances)